Abstract

Sprouting angiogenesis is the formation of new capillaries from existing vessels in response to tissue hypoxia due to growth/development, repair/healing, and also chronic inflammation. In this study, we aimed to elucidate the effect of IL-6, a pleiotropic cytokine with both pro-inflammatory and anti-inflammatory functions, in regulating the sprouting angiogenic response of endothelial cells (ECs). We found that activation of IL-6 trans-signaling inhibited the migration, proliferation, and tube formation ability of ECs. In addition, inhibition of the autocrine IL-6 classic-signaling by depleting endogenous IL-6 from ECs impaired their tube formation ability. At the molecular level, we found that IL-6 trans-signaling in ECs upregulated established endogenous anti-angiogenic factors such as CXCL10 and SERPINF1 while at the same time downregulated known endogenous pro-angiogenic factors such as cKIT and CXCL8. Furthermore, prior activation of ECs by IL-6 trans-signaling alters their response to vascular endothelial growth factor-A (VEGF-A), causing an increased p38, but decreased Erk1/2 phosphorylation. Collectively, our data demonstrated the dual facets of IL-6 in regulating the sprouting angiogenic function of ECs. In addition, we shed light on molecular mechanisms behind the IL-6 trans-signaling mediated impairment of endothelial sprouting angiogenic response.

Highlights

  • Sprouting angiogenesis is the growth of new capillaries from pre-existing vessels in response to tissue hypoxia due to growth, development, and repair [1]

  • We further investigated whether IL-6 trans-signaling interfered with vascular endothelial growth factor-A (VEGF-A) signaling by pre-treating HUVECs with IL-6/soluble form of IL-6R (sIL-6R) (48 h), followed by stimulation with VEGF-A for 5 min to 30 min

  • We demonstrated that activation of IL-6 trans-signaling impaired response of vascular endothelial cells (ECs)

Read more

Summary

Introduction

Sprouting angiogenesis is the growth of new capillaries from pre-existing vessels in response to tissue hypoxia due to growth, development, and repair [1]. It involves degradation of the extracellular matrix, migration, differentiation, and proliferation of endothelial cells (ECs) [1,2]. (VEGFR-2) expressed on ECs that, upon ligand binding, dimerizes and trans-phosphorylates tyrosine residues in its intracellular domain [5] It subsequently provokes downstream signaling pathways including PI3K/Akt, p38/MAPK, and pErk/MAPK pathways that regulate survival/permeability, migration, and proliferation [6,7,8,9]

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call